However, although the lower dose failed to alter insulin levels, the levels of TNF-α or IL-6, apoptotic markers in the control, or T2DM-treated rats—it reduced fasting glucose levels in control rats, thus suggesting a potent hypoglycemic effect. Here, IL6 is linked to type 2 diabetes mellitus.